Average Co-Inventor Count = 6.18
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mirati Therapeutics, Inc. (26 from 38 patents)
2. Array Biopharma Inc. (9 from 329 patents)
3. Pfizer Products Inc. (47 patents)
26 patents:
1. 12421228 - Naphthyridine derivatives as PRC2 inhibitors
2. 12421253 - Tetrahydropyridopyrimidine pan-KRas inhibitors
3. 12398154 - Azaquinazoline pan-KRas inhibitors
4. 12371435 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
5. 12304915 - SOS1 inhibitors
6. 12252493 - Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
7. 11999753 - Tetrahydropyridopyrimidine pan-KRas inhibitors
8. 11964989 - KRas G12D inhibitors
9. 11932633 - KRas G12C inhibitors
10. 11702418 - SOS1 inhibitors
11. 11548888 - KRas G12C inhibitors
12. 11492351 - MTA-cooperative PRMT5 inhibitors
13. 11485738 - Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
14. 11479551 - MTA-cooperative PRMT5 inhibitors
15. 11453683 - KRas G12D inhibitors